These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8385257)

  • 1. Effects of chronic stimulation or antagonism of opiate receptors on GH secretion in male and female rats.
    Simpkins JW; Millard WJ; Berglund LA
    Life Sci; 1993; 52(17):1443-50. PubMed ID: 8385257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor activation resets the hypothalamic clock generating growth hormone secretory bursts in the rat.
    Willoughby JO; Medvedev A
    J Endocrinol; 1996 Jan; 148(1):149-55. PubMed ID: 8568462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate inhibition of growth hormone secretion in young chickens.
    Harvey S; Scanes CG
    Gen Comp Endocrinol; 1987 Jan; 65(1):34-9. PubMed ID: 3803900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate modulation of growth hormone secretion is compromised during the steroid-induced luteinizing hormone surge.
    Singh M; Simpkins JW; Layden MP; Romano TM; Millard WJ
    Neuroendocrinology; 1992 Feb; 55(2):214-20. PubMed ID: 1620289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a sustained-release naloxone pellet on luteinizing hormone secretion in female rats.
    Gabriel SM; Simpkins JW
    Neuroendocrinology; 1983 Nov; 37(5):342-8. PubMed ID: 6139759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
    Koenig JI; Mayfield MA; McCann SM; Krulich L
    Life Sci; 1984 May; 34(19):1829-37. PubMed ID: 6330479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid regulation of luteinizing hormone secretion in the male rat.
    Miller MA; Bremner WJ; Clifton DK; Dorsa DM; Steiner RA
    Biol Reprod; 1986 Aug; 35(1):17-26. PubMed ID: 3741948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices.
    Vathy I; Etgen AM
    Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
    Ebling FJ; Schwartz ML; Foster DL
    Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic morphine treatment enhances the negative and positive feedback effects of estradiol on gonadotropin secretion in ovariectomized rats.
    Gabriel SM; Berglund LA; Simpkins JW
    Endocrinology; 1987 May; 120(5):1799-805. PubMed ID: 3032570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term adult exposure to estradiol feminizes the male pattern of spontaneous and growth hormone-releasing factor-stimulated growth hormone secretion in the rat.
    Painson JC; Thorner MO; Krieg RJ; Tannenbaum GS
    Endocrinology; 1992 Jan; 130(1):511-9. PubMed ID: 1345780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prolactin and growth hormone responses to naloxone and intracerebral ventricle morphine administration in heifers.
    Leshin LS; Rund LA; Thompson FN; Mahaffey MB; Chang WJ; Byerley DJ; Kiser TE
    J Anim Sci; 1990 Jun; 68(6):1656-65. PubMed ID: 2384365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal steroids do not affect basal growth hormone response to naloxone in humans.
    Monteleone P; Maj M; Iovino M; Fiorenza L; Fiumani PM; Steardo L
    Psychopharmacology (Berl); 1987; 93(2):268-70. PubMed ID: 2827218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig.
    Giri M; Kaufman JM
    Endocrinology; 1994 Nov; 135(5):2137-43. PubMed ID: 7956937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mu-Opioid agonists stimulate growth hormone secretion in immature rats.
    Eason MG; Francis RS; Kuhn CM
    Neuroendocrinology; 1996 Jun; 63(6):489-97. PubMed ID: 8793890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.